Medplus Health Services

Medplus Health Services

785.10
-23.15
(-2.86%)
hide
Key Fundamentals
Add Ratio
Market Cap
9,684.70 Cr
EPS
12.57
PE Ratio
48.25
Dividend Yield
0.00 %
Industry
Retail
52 Week High
1,045.30
52 Week Low
642.00
PB Ratio
5.10
Debt to Equity
0.64
Analyst Rating and Forecast
- By Refinitiv from6 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Medplus Health Services reported quarterly net profit of 555 million rupees compared to 387 million rupees in the same period last year. Revenue increased to 16.79 billion rupees from 15.76 billion rupees year-on-year. EBITDA rose to 1.5 billion rupees from 1.24 billion rupees, while EBITDA margin improved to 8.86% from 7.89% in the previous year.
negative
MedPlus Health Services Limited disclosed that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a drug license of a store located in Shanti Nagar, Nagpur, Maharashtra. The suspension is for twenty-one days and was issued by the Assistant Commissioner Licensing Authority, Food Drug Administration, Maharashtra, Nagpur. The order was received on November 1, 2025, under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of Rs 4.34 lacs due to this suspension.
positive
MedPlus Health Services Limited has received two stay orders against a suspension from authorities in Nagpur and Amravati, Maharashtra. The company referenced earlier submissions made on August 6, 2025 and August 14, 2025 regarding the suspension matter. The stay orders will be made available on the company's website and stock exchange websites.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
785.10
#1 9,684.70
#2 48.25
#1 6,184.70
#2 9.18
#1 150
#2 43.41
52.12
1,057.60
4,699.00
#1 39.26
5,135.30
#1 30.45
107
#1 47.32
35.75
52.55
60.20
-
9.20
-4.17
-2
-166.67
68.28

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
9.18 %
Net Income Growth
128.96 %
Cash Flow Change
275.98 %
ROE
107.45 %
ROCE
49.93 %
EBITDA Margin (Avg.)
24.43 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
810
810
959
932
941
979
1,004
1,132
1,202
1,267
1,294
1,419
1,451
1,501
1,498
1,588
1,574
1,525
1,558
1,697
Expenses
743
745
859
863
872
914
941
1,061
1,119
1,171
1,213
1,324
1,350
1,385
1,395
1,452
1,429
1,373
1,412
1,531
EBITDA
67
65
101
69
69
65
63
71
83
95
81
96
102
116
103
136
145
152
146
166
Operating Profit %
7 %
7 %
10 %
7 %
7 %
5 %
5 %
5 %
6 %
7 %
6 %
6 %
6 %
7 %
6 %
8 %
8 %
9 %
8 %
9 %
Depreciation
22
24
27
28
31
34
38
42
46
56
52
56
57
59
60
63
63
64
66
69
Interest
13
15
15
16
17
19
20
20
21
22
23
24
25
25
25
25
26
27
27
29
Profit Before Tax
32
26
58
25
22
13
5
9
16
17
5
16
20
32
18
48
57
61
53
69
Tax
9
8
12
5
5
1
1
2
3
-9
1
2
6
-2
4
9
11
10
10
13
Net Profit
23
18
46
20
17
11
4
7
13
27
4
15
14
34
14
39
46
51
42
56
EPS in ₹
2.21
1.76
4.34
1.85
1.53
0.99
0.27
0.55
1.12
2.24
0.32
1.22
1.15
2.81
1.20
3.24
3.84
4.32
3.54
4.63

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Fixed Assets
67
77
81
84
90
420
517
799
1,138
1,242
1,296
Current Assets
317
376
397
458
475
816
923
1,632
1,481
1,568
1,844
Capital Work in Progress
3
4
0
1
1
5
6
20
26
11
16
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
368
429
457
560
582
924
1,043
1,775
1,633
1,752
2,047
Total Liabilities
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Current Liabilities
210
269
278
326
337
481
415
559
477
526
577
Non Current Liabilities
74
91
111
15
11
339
420
618
830
902
1,044
Total Equity
154
150
149
304
325
529
731
1,417
1,491
1,577
1,740
Reserve & Surplus
141
137
149
303
325
528
359
1,394
1,467
1,554
1,717
Share Capital
12
12
0
0
0
0
0
24
24
24
24

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
32
-15
-10
14
45
56
-37
-93
350
-137
-5
Investing Activities
-16
-32
-15
-18
-19
-28
-35
-703
429
-83
-318
Operating Activities
-19
-17
34
32
147
-7
3
170
90
144
540
Financing Activities
67
35
-29
-1
-83
90
-6
440
-170
-198
-228

Share Holding

% Holding
Aug 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
96.68 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.41 %
40.45 %
40.39 %
40.39 %
40.39 %
40.39 %
40.34 %
40.32 %
40.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
12.36 %
0.00 %
14.94 %
14.85 %
14.72 %
15.23 %
15.61 %
16.42 %
16.54 %
DIIs
0.00 %
11.61 %
11.99 %
14.96 %
14.31 %
28.77 %
28.16 %
13.62 %
25.49 %
16.28 %
22.47 %
22.17 %
27.97 %
25.65 %
26.19 %
26.04 %
26.52 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
6.38 %
5.83 %
5.88 %
6.22 %
6.21 %
6.13 %
5.83 %
6.40 %
6.15 %
7.30 %
7.56 %
11.84 %
13.21 %
13.10 %
12.59 %
12.22 %
Others
3.32 %
41.58 %
41.75 %
38.73 %
39.05 %
24.59 %
25.28 %
40.12 %
15.33 %
37.12 %
14.90 %
15.03 %
5.07 %
5.52 %
4.77 %
4.64 %
4.43 %
No of Share Holders
69
3,42,917
82,627
77,119
76,972
74,702
73,512
70,017
66,430
66,048
74,976
76,934
87,328
83,912
83,439
81,742
78,337

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
15 Dec 2023 813.50 734.65
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 682.10 689.45
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 650.80 674.95
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 847.90 730.65
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 732.15 977.00
02 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Aug 2025 853.60 915.25
15 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
15 Sept 2025 915.25 838.75
31 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Oct 2025 757.45 757.85

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome7 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome2 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20154 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20155 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20155 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation6 days ago
Un-Audited Financial Results For The Quarter And Half Year Ended September 30 20256 days ago
Board Meeting Outcome for Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30 20256 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 25, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 22, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 19, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 15, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 14, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 11, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 09, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 07, 2025
Board Meeting Intimation for Consider & Approve Un-Audited Financial Result For Quarter And Half Year Ended September 30 2025Sep 30, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 30, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 28, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 25, 2025
Closure of Trading WindowSep 23, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 22, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 19, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 18, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 16, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 15, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 10, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 09, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 05, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 04, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 23, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 23, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 22, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 21, 2025
Reg. 34 (1) Annual Report.Aug 21, 2025
Notice Of 19Th Annual General Meeting Of The Company For The Financial Year 2024-25Aug 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 19, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 15, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 13, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 04, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
SBI ELSS Tax Saver Fund Direct-Growth
0.00%
-3997983
-1.00%
-1.12%
Nippon India Pharma Fund Direct-Growth
0.00%
-3627277
-3.39%
-3.65%
Kotak Small Cap Fund Direct-Growth
0.00%
-3578425
-1.55%
-1.72%
Nippon India Multi Cap Fund Direct-Growth
0.00%
-2527912
-0.40%
-0.46%
Franklin India Small Cap Fund Direct-Growth
0.00%
-2432539
-1.39%
-1.54%
Nippon India Focused Fund Direct-Growth
0.00%
-2098553
-1.88%
-2.10%
Franklin India Flexi Cap Fund Direct-Growth
0.00%
-1132626
-0.45%
-0.51%
Invesco India Contra Fund Direct-Growth
0.00%
-1094617
-0.43%
-0.49%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
-937074
-1.14%
-1.28%
ICICI Prudential India Opportunities Fund Direct - Growth
0.00%
-715753
-0.18%
-0.20%
SBI Healthcare Opportunities Fund Direct Plan-Growth
0.00%
-451699
-0.87%
-0.08%
Nippon India Flexi Cap Fund Direct - Growth
0.00%
-450000
-0.37%
-0.42%
Bandhan Small Cap Fund Direct-Growth
0.00%
-394694
-0.19%
-0.23%
Kotak Pioneer Fund Direct - Growth
0.00%
-393797
-0.95%
-1.09%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.00%
-244605
-0.71%
-0.81%
Quant Consumption Fund Direct - Growth
0.00%
-208127
-6.86%
-7.50%
DSP Healthcare Fund Direct - Growth
0.00%
-192078
-0.47%
-0.52%
Nippon India Multi Asset Allocation Fund Direct - Growth
0.00%
-182368
-0.18%
-0.22%
Nippon India Aggressive Hybrid Fund Direct-Growth
0.00%
-169000
-0.32%
-0.37%
Kotak Business Cycle Fund Direct - Growth
0.00%
-156517
-0.40%
-0.45%
Bandhan Balanced Advantage Fund Direct-Growth
0.00%
-137834
-0.46%
-0.54%
Franklin India ELSS Tax Saver Fund Direct-Growth
0.00%
-122459
-0.14%
-0.16%
Bajaj Finserv Small Cap Fund Direct-Growth
0.00%
-118997
-0.65%
-0.79%
Tata India Pharma & Healthcare Fund Direct-Growth
0.00%
-118808
-0.69%
-0.76%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-115000
-1.42%
-1.32%

Technical Indicators

RSI(14)
Neutral
60.93
ATR(14)
Volatile
25.93
STOCH(9,6)
Neutral
38.76
STOCH RSI(14)
Overbought
94.10
MACD(12,26)
Bullish
7.91
ADX(14)
Strong Trend
27.65
UO(9)
Bearish
46.25
ROC(12)
Uptrend And Accelerating
6.36
WillR(14)
Neutral
-48.64